Showing 2,161 - 2,180 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((all decrease) OR (fold decrease)) ))', query time: 0.51s Refine Results
  1. 2161
  2. 2162
  3. 2163
  4. 2164
  5. 2165
  6. 2166

    Table 1_Gender difference in the association between composite dietary antioxidant index and all-cause mortality.docx by Lanzhi Duan (15350413)

    Published 2025
    “…The restricted cubic spline revealed that the hazard ratio (HR) of all-cause mortality decreased significantly with increasing CDAI. …”
  7. 2167

    Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  8. 2168

    Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  9. 2169

    Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  10. 2170
  11. 2171
  12. 2172

    Image 2_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…After COX regression, restricted cubic spline analysis, and subgroup analyses, it was found that a significant increase or decrease in HGI adversely affected long-term survival.…”
  13. 2173

    Image 1_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…After COX regression, restricted cubic spline analysis, and subgroup analyses, it was found that a significant increase or decrease in HGI adversely affected long-term survival.…”
  14. 2174

    Table 1_The association between oxidative balance scores and all-cause mortality and cancer-specific mortality in cancer survivors: a retrospective cohort study.doc by Ran He (207626)

    Published 2025
    “…</p>Conclusion<p>The study reveals a significant linear negative association between OBS in cancer survivors and both all-cause and cancer-specific mortality.…”
  15. 2175
  16. 2176
  17. 2177
  18. 2178
  19. 2179

    Data for Fig 6D. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
  20. 2180